Blue Jet Healthcare Limited IPO
Blue Jet Healthcare Limited was a mainboard IPO in the Pharmaceuticals sector, offered at ₹329–₹346 per share to raise ₹840 crore. The issue was subscribed 7.95× overall (QIBs 13.72×, NIIs 13.59×, retail 2.24×). It listed on 1 Nov 2023 at ₹380 and closed its first day at ₹413, a listing gain of +19.5% versus the ₹346 issue price. It now trades around ₹505 (+45.8% versus the issue price).
Frequently asked questions
- How many times was the Blue Jet Healthcare Limited IPO subscribed?
- The Blue Jet Healthcare Limited IPO was subscribed 7.95× overall — 13.72× in the QIB category, 13.59× among non-institutional investors, 2.24× in retail.
- What were the Blue Jet Healthcare Limited IPO listing gains?
- Blue Jet Healthcare Limited listed on 1 Nov 2023 at ₹380, closing its first day at ₹413 — a listing gain of +19.5% versus the ₹346 issue price.
- What were the retail allotment odds for the Blue Jet Healthcare Limited IPO?
- Retail was subscribed 2.24×, so a single-lot application had roughly a 44.6% chance of allotment (about 1 in 2), and allotment was finalised on 26 Oct 2023.
- What was the price band and lot size of the Blue Jet Healthcare Limited IPO?
- The price band was ₹329–₹346 per share, with a minimum lot of 43 shares (₹14,878 at the upper band).
- Who were the registrar and lead manager for the Blue Jet Healthcare Limited IPO?
- Link Intime India Private Limited was the registrar, and Kotak Mahindra Capital was the book-running lead manager.